TICKPLEX
LIVE

Serial Number

79213964

Owner

Te?ted Oy

Attorney

Elizabeth A. Cominolli

Filing Date

Nov 11, 2016

Add to watchlist:

No watchlists yet
View on USPTO

TICKPLEX Trademark

Serial Number: 79213964 • Registration: 5634880

TICKPLEX is a trademark filed by Te?ted Oy on November 11, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Te?ted Oy

Mattilanniemi 6
JYVÄSKYLÄ FI-40100 , FI

Entity Type: 99

Jyväskylän yliopisto

PL 35

Entity Type: 99

Trademark Details

Filing Date

November 11, 2016

Registration Date

December 25, 2018

Published for Opposition

October 9, 2018

Goods & Services

Medical apparatus and instruments in the field of pathogen and toxin detection and identification; testing apparatus for medical purposes, namely, blood testing apparatus [ ; medical instruments for infectious disease testing, namely, biosensors for detecting infectious disease; diagnostic testing instruments for use in detection infectious diseases, namely, biosensors for detecting infectious disease ]

Sanitary preparations for medical purposes; chemical preparations for medical purposes, namely, [ for treating hypertension, ] reagents for medical diagnosis; bacterial preparations for medical [ and veterinary ] use; bacteriological preparations for medical [ and veterinary ] use; antigens, namely, diagnostic reagents for medical use; diagnostic preparations, namely, diagnostic reagents for medical use; diagnostic reagents for medical use; diagnostic reagents for medical use for sale in kit form; chemical reagents for medical [ or veterinary ] purposes; clinical diagnostic reagents; clinical medical reagents; medical diagnostic reagents and assays for detecting pathogens am co-infections in kit form; antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; reagent paper for medical [ or veterinary ] purposes

[ Scientific apparatus and instruments, namely, laboratory glassware, laboratory flasks, laboratory swabs, laboratory, magnetic separators, spectrometers; laboratory instruments, other than for medical use, namely, chromatography apparatus and columns, centrifuges as well as for the detection of pathogens and toxins in a biological sample for research use; ] laboratory instruments for the detection of pathogens and toxins in a biological sample for research use; laboratory trays; incubation plates for scientific or laboratory use

Chemicals used in industry and science; [ chemical substances, chemical materials and chemical preparations, and chemical elements for use in manufacture, namely, chemical additives for use in manufacture of pharmaceuticals; ] chemicals for use in analysis, namely, chemical preparations for laboratory analysis, other than medical and veterinary analysis; diagnostic preparations used in science; diagnostic preparations, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; chemical compositions and materials in the nature of solutions for use in science; chemical reagents, other than for medical or veterinary purposes; Diagnostic reagents for medical laboratory use; Chemical and diagnostic reagents for use in antibody screening and pathogen identification; Chemical and diagnostic reagents for use in conducting enzyme-linked immunosorbent assays; chemical test reagents, other than medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical reagent mixtures, other than for medical or veterinary use; [ proteins for use in science, namely, protein arrays for scientific research; ] reagents for scientific purposes, namely, reagents for scientific research; reagents for research purposes; reagents for medical research; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents, other than for medical use for sale in kit form namely, for scientific research; reagents in kit form for conducting enzyme-linked immunosorbent assay, other than medical and veterinary use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; monoclonal antibody reagents, other than for medical use; [ chemical components for producing a radiolabeled monoclonal antibody for industrial or scientific use; ] Bacteria and bacteriological preparation for use in conducting enzyme-linked immunosorbent assays, and for use in antibody screening and pathogen identifications, and not for medical and veterinary use; [ bacteriological preparations other than for medical and veterinary use, namely, bacteria for use in pharmaceutical manufacturing; ] protein raw material, namely, for [ use in the manufacturing of pharmaceuticals, food supplements and for ] laboratory use in scientific research [ ; carbon; silver nitrate; oxide for industrial use ]

[ Scientific and technological services and research and design relating thereto, namely, scientific research and development in the field of pharmaceutical and biotechnology; industrial analysis and research services in the field of pharmaceuticals; research and development of new products for others; research and development services in the field of antibody technology; research and development services in the field of antibodies; research and development services in the field of bacteriology; scientific laboratory services; laboratory research in the field of bacteriology, pharmaceuticals, antibodies, pathogens and toxins; ; laboratory testing in the field of new pharmaceutical products; Laboratory testing of antibodies, pathogens and toxins, laboratory testing of patient samples for the detection and identification of antibodies, pathogens and toxins; Consultancy in the field of laboratory testing, namely medical laboratory services consultancy relating to laboratory testing and new pharmaceutical products; biochemical research and development; biochemical research and analysis; chemical analysis; bacteriological research; laboratory services, namely scientific research in the field of production of monoclonal antibodies ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 29, 2025 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2025 NREP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NURC
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 29, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Apr 29, 2025 71.P
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 29, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 28, 2025 APRE
TEAS SECTION 71 RECEIVED
Dec 19, 2024 ES71
TEAS SECTION 7 REQUEST RECEIVED
Dec 6, 2024 ES7R
NEW REPRESENTATIVE AT IB RECEIVED
Mar 21, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 25, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 31, 2019 FINO
CORRECTION UNDER SECTION 7 - PROCESSED
May 21, 2019 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 20, 2019 APRE
TEAS SECTION 7 REQUEST RECEIVED
May 7, 2019 ES7R
GENERIC MADRID TRANSACTION SENT TO IB
Apr 5, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 5, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 25, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 25, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 9, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 9, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Oct 6, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 19, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 19, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 19, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2018 CNSA
ASSIGNED TO EXAMINER
Aug 20, 2018 DOCK
EXAMINER'S AMENDMENT ENTERED
Aug 20, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 20, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 20, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 20, 2018 CNEA
ASSIGNED TO EXAMINER
Aug 20, 2018 DOCK
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 23, 2018 GNFN
FINAL REFUSAL E-MAILED
Feb 23, 2018 GNFR
FINAL REFUSAL WRITTEN
Feb 23, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2018 TROA
REFUSAL PROCESSED BY IB
Oct 21, 2017 RFNT
CHANGE OF OWNER RECEIVED FROM IB
Oct 13, 2017 CHLD
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 22, 2017 RFCS
REFUSAL PROCESSED BY MPU
Aug 22, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Aug 19, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 18, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 17, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 10, 2017 REPR